TrialJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2015

Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials.

Maria Octavia Rangel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.